5 hours ago
1
stocknshares
Sandoz (OTCQX:SDZNY) announced on Tuesday that Regeneron (NASDAQ:REGN) has agreed to settle a patent litigation related to a copycat version of Eylea, a blockbuster eye care medicine that the U.S. firm currently markets with Bayer (OTCPK:BAYZF).
As part of the
© FBT Company 2025. All rights are reserved
English (US) ·